159 related articles for article (PubMed ID: 202907)
1. Comparative evaluation of lymphocyte subpopulations, delayed cutaneous hypersensitivity reactions and autoantibody formation in cancer patients.
Pichler WJ; Stingl G; Wagner G; Micksche M; Neumann H; Knapp W
Osterr Z Onkol; 1977 Nov; 4(5-6):110-7. PubMed ID: 202907
[No Abstract] [Full Text] [Related]
2. [Immune evaluation of cervical cancer patients--alteration of peripheral lymphocyte subpopulations--(author's transl)].
Ishiguro T
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):719-24. PubMed ID: 6972426
[TBL] [Abstract][Full Text] [Related]
3. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
[TBL] [Abstract][Full Text] [Related]
4. Delayed cutaneous hypersensitivity reactions to membrane extracts of carcinomatous cells of the cervix uteri.
Wells SA; Melewicz FC; Christiansen C; Ketcham AS
Surg Gynecol Obstet; 1973 May; 136(5):717-20. PubMed ID: 4701902
[No Abstract] [Full Text] [Related]
5. [Evaluation of peripheral lymphocytes in patients with solid malignant tumors].
Rumi LS; Eugui EM; Balbiani RL; Barañao RI
Medicina (B Aires); 1981; 41(2):132-6. PubMed ID: 7278611
[No Abstract] [Full Text] [Related]
6. Delayed cutaneous hypersensitivity reactions to tumor cell antigens and to nonspecific antigens. Prognostic significance in patients with lung cancer.
Wells SA; Burdick JF; Joseph WL; Christiansen CL; Wolfe WG; Adkins PC
J Thorac Cardiovasc Surg; 1973 Oct; 66(4):557-62. PubMed ID: 4755446
[No Abstract] [Full Text] [Related]
7. Correlation of immune reactivity and clinical status in cancer.
Chretien PB; Catalona WJ; Twomey PL; Sample WF
Ann Clin Lab Sci; 1974; 4(5):331-8. PubMed ID: 4851196
[No Abstract] [Full Text] [Related]
8. Demonstration of tumor-associated delayed cutaneous hypersensitivity reactions in patients with lung cancer and in pateients with carcinoma of the cervix.
Wells SA; Burdick JF; Christiansen C; Ketcham AS; Adkins PC
Natl Cancer Inst Monogr; 1973 Jun; 37():197-203. PubMed ID: 4713780
[No Abstract] [Full Text] [Related]
9. Rosette formation and inhibition in cervical dysplasia and carcinoma in situ.
Sawanobori S; Ashman RB; Nahmias AJ; Benigno BB; LaVia MF
Cancer Res; 1977 Dec; 37(12):4332-5. PubMed ID: 922724
[TBL] [Abstract][Full Text] [Related]
10. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
[TBL] [Abstract][Full Text] [Related]
11. [Changes in certain immunological parameters in patients with malignant skin melanoma].
Lukács L; Bárdosi L; Somos Z; Kocsis B
Orv Hetil; 1985 Apr; 126(14):819-26. PubMed ID: 3873050
[No Abstract] [Full Text] [Related]
12. [Cytotoxicity of lymphocytes against autologous cultured primary lung cancer cells in relation to histological type and clinical stage].
Kimura H; Yamaguchi Y; Kadoyama C; Matsumoto A
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2175-81. PubMed ID: 3013100
[TBL] [Abstract][Full Text] [Related]
13. Serum factors inhibiting E-rosette formation in patients with lung malignancies.
Saiz-Garcia F; Rodriguez-Valverde V
Bull Cancer; 1981; 68(4):346-9. PubMed ID: 6274454
[No Abstract] [Full Text] [Related]
14. E rosettes in the uranium miners with lung cancer.
Kudrna K; Andrlíková J; Smíd A; Stipl Z
Czech Med; 1979; 2(3):141-7. PubMed ID: 231508
[TBL] [Abstract][Full Text] [Related]
15. Delayed-hypersensitivity reactions to soluble membrane antigens of human malignant lung cells.
Hollinshead AC; Stewart TH; Herberman RB
J Natl Cancer Inst; 1974 Feb; 52(2):327-38. PubMed ID: 4131424
[No Abstract] [Full Text] [Related]
16. [The skin tests in operability evaluation of patients with non-small cell cancer of the lungs].
Biondo FG; Caldarelli L; Bergaminelli C; Perillo G
Arch Monaldi Mal Torace; 1988; 43(3):265-70. PubMed ID: 2855917
[No Abstract] [Full Text] [Related]
17. [Suppressor activity induced by concanavalin A in peripheral blood lymphocytes of patients with solid malignant tumors].
García MS; Barañao RI; Fernández O; Rumi LS
Acta Physiol Lat Am; 1983; 33(1):15-20. PubMed ID: 6229133
[TBL] [Abstract][Full Text] [Related]
18. [Delayed immunity in bronchial cancer: lymphocyte activation in culture with phytohemagglutinins and tuberculin PPD compared with the skin response to tubercular antigens].
Piacentini G; Ferrari S; Megale C; Ippoliti F
Boll Ist Sieroter Milan; 1973; 52(3):230-6. PubMed ID: 4762779
[No Abstract] [Full Text] [Related]
19. [Activated cells in the peripheral blood in lung cancer].
Qian L
Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):18-21, 62. PubMed ID: 2848634
[No Abstract] [Full Text] [Related]
20. Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
Waanders GA; Rimoldi D; Liénard D; Carrel S; Lejeune F; Dietrich PY; Cerottini JC; Romero P
Clin Cancer Res; 1997 May; 3(5):685-96. PubMed ID: 9815737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
